CoChat

The DOI matches its Crossref record; 85 of the 92 references it cites were found in a registry or an index.

Severity of Withdrawal Symptoms, Plasma Oxytocin Levels, and Treatment Outcome in Heroin Users Undergoing Acute Withdrawal

Nikolaou, Kakia, Kapoukranidou, Dorothea, Ndungu, Samuel, Floros, Georgios, Kovatsi, Leda · 2017 · Journal of Psychoactive Drugs

Abstract

Pre-clinical studies show that, following chronic opioid exposure, oxytocin neurons exhibit over-excitation upon withdrawal, causing an increase in oxytocin brain and plasma levels. Relevant clinical data on humans are scarce. This study investigates the opioid withdrawal stress effect on oxytocin plasma levels in humans. We evaluated 57 male chronic heroin users in a residential detoxification program. We determined plasma oxytocin levels by ELISA and measured the stress effects of withdrawal using the COWS scale for opioid withdrawal, the VAS scale for craving, and the Hamilton scales for anxiety and depression on the second day of admission. Out of the 57 patients enrolled in the study, 27 completed the 21-day program, while the remaining 30 dropped out prior to completion. Plasma oxytocin levels were significantly higher in those individuals who dropped out than in those who completed the program. Participants who dropped out at some stage scored higher in the COWS, VAS-Craving, and Hamilton-anxiety scales, indicating a higher stress and explaining the higher oxytocin levels. In addition, plasma oxytocin levels correlated positively with the scores achieved in the COWS and Hamilton-anxiety scales. Higher withdrawal stress levels are associated with higher plasma oxytocin levels and early treatment discharge.

Overview

Integrity signals

Registry

Crossref · 10.1080/02791072.2017.1312644

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 92 references

Research works printed but not linked: 8

  1. 10.1111/adb.2010.15.issue-4 · doi:10.1111/adb.2010.15.issue-4
  2. 10.1111/jne.1991.3.issue-5 · doi:10.1111/jne.1991.3.issue-5
  3. 10.1002/da.2012.29.issue-11 · doi:10.1002/da.2012.29.issue-11
  4. Jesova D., 1996, Acta Neurobiologiae Experimentalis, 56, 779
  5. 10.1111/acer.2013.37.issue-3 · doi:10.1111/acer.2013.37.issue-3
  6. 10.1111/adb.2011.16.issue-2 · doi:10.1111/adb.2011.16.issue-2
  7. Smyth B. P., 2010, Irish Medical Journal, 103, 176
  8. 10.1111/psyp.2007.44.issue-3 · doi:10.1111/psyp.2007.44.issue-3

Cited by

See all 18

Metadata

Authors
Nikolaou, K., Kapoukranidou, D., Ndungu, S., Floros, G., & Kovatsi, L.
Affiliations
  • G. Papanikolaou General Hospital (GR)
  • Associate Professor, Department of Physiology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
  • Aristotle University of Thessaloniki (GR)
Corresponding author
Kovatsi, Leda
Venue
Journal of Psychoactive Drugs
Published
2017-04-26
Volume
49
Issue
3
Pages
233-241
ISSN
  • 0279-1072 (ISSN-L)
  • 2159-9777
OpenAlex
W2610111816
Cited by
18
References
92
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2021: 5 · 2020: 2 · 2019: 2 · 2018: 2
FWCI
1.54
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Psychoactive Drugs (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
Keywords
heroin withdrawal, plasma oxytocin, chronic opioid users, treatment discontinuation, withdrawal symptoms, craving, anxiety, depression, Hamilton Anxiety Rating Scale
MeSH terms
Adult, Heroin Dependence, Humans, Male, Oxytocin, Patient Dropouts, Severity of Illness Index, Substance Withdrawal Syndrome, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Severity of Withdrawal Symptoms, Plasma Oxytocin Levels, and Treatment Outcome in Heroin Users Undergoing Acute Withdrawal. https://app.cochat.ai/papers/10.1080/02791072.2017.1312644
The paper
Nikolaou, K., Kapoukranidou, D., Ndungu, S., Floros, G., & Kovatsi, L. (2017). Severity of Withdrawal Symptoms, Plasma Oxytocin Levels, and Treatment Outcome in Heroin Users Undergoing Acute Withdrawal. Journal of Psychoactive Drugs. https://doi.org/10.1080/02791072.2017.1312644

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.